About two-thirds of the country’s population preferred to receive American-made Covid-19 shots, results of a nationwide survey released on Monday showed.

Of the 1,200 adult Filipinos polled by the Social Weather Stations, 66 percent said they preferred vaccines from the US.

The survey was conducted from April 28 to May 2. During the time of the survey, a US-made vaccine had yet to arrive in the country, and only Chinese, British and Russian vaccines were available.

Nineteen percent of the respondents preferred Chinese vaccines, while Japanese, Australian and British vaccines were each chosen by 13 percent of respondents. Twelve percent chose Russian vaccines.

Germany (eight percent), Korea (six percent) and India (three percent) also received votes.

Two percent chose all 10 countries, while twelve percent did not give an answer.

Sinovac is Pinoys’ most preferred brand

When it came to brand recall however, China’s Sinovac vaccine came out on top.

It was preferred by 39 percent of the respondents after being asked the question, “If you could choose the brand of vaccine approved by the Food and Drug Administration of the Philippines, which of the following would you choose?”

The Pfizer-BioNTech vaccine (39 percent) was the second-most preferred brand. AstraZeneca and Johnson & Johnson vaccines were preferred by 22 percent and 10 percent of respondents, respectively.

Other preferred vaccines were Moderna (7 percent), CureVac (3 percent), Sinopharm (3 percent), Novavax (3 percent), Sanofi-GSK (3 percent) and Gamaleya (2 percent).

The Philippines has received 8,279,050 Covid-19 doses.

Of the total, 5.5 million were Sinovac doses, 2.55 million were AstraZeneca doses, 193,050 were Pfizer doses and 30,000 were Sputnik V doses. John Ezekiel J. Hirro